Adaptimmune Therapeutics Plc ADR’s recent filing unveils that its Chief Financial Officer Wood Gavin unloaded Company’s shares for reported $950.0
In a filing, Adaptimmune Therapeutics Plc ADR revealed its Chief Financial Officer Wood Gavin unloaded Company’s shares for reported $950.0
In a filing, Adaptimmune Therapeutics Plc ADR revealed its Chief Operating Officer Bertrand William C JR unloaded Company’s shares for
Adaptimmune Therapeutics Plc ADR’s filing revealed that its Director Behbahani Ali unloaded Company’s shares for reported $0.18 million on Aug
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Adaptimmune Therapeutics Plc ADR revealed its Affiliate New Enterprise Associates, 14 acquired Company’s shares for reported $0.98
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Adaptimmune Therapeutics Plc ADR revealed its 10% Owner EcoR1 Capital, LLC unloaded Company’s shares for reported $3.82
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Adaptimmune Therapeutics Plc ADR revealed its 10% Owner EcoR1 Capital, LLC unloaded Company’s shares for reported $3.82